The purpose of this review is to conduct a critical analysis of the most recent evidences from the medical literature with respect to the pathophysiology of CMV infection and its association with ...

BioViva’s journey in gene therapy began with its use of an adeno-associated virus (AAV ... in the treatment of complex disorders,” said Church. BioViva’s early-stage CMV projects are ...

Takeda (NYSE:TAK) said Chinese regulators have approved its drug Livtencity for the treatment of adults with post-transplant CMV disease ... cytomegalovirus infection or disease that is refractory ...